CryoPort Inc (NAS:CYRX)
$ 13.33 -0.13 (-0.97%) Market Cap: 656.60 Mil Enterprise Value: 651.27 Mil PE Ratio: 0 PB Ratio: 1.48 GF Score: 81/100

Cryoport, Inc. - Special Call Transcript

Jul 29, 2020 / 03:00PM GMT
Release Date Price: $32.71 (-0.52%)
Agnes Shanley;MJH Associates;Senior Editor

Hello, everyone. Welcome to today's Editors' Series broadcast, Cell and Gene Therapies: Laying the Foundation for a New Supply Chain. This is Agnes Shanley, Senior Editor of BioPharm International and Pharmaceutical Technology, and I'll be moderating today's event.

This webcast will explore some of the challenges presented by scaling up cell and gene therapies and how a vein-to-vein supply chain partnership is benefiting them.

It is presented by BioPharm International and Pharmaceutical Technology in conjunction with INTERPHEX, the premier pharmaceutical, biotechnology and device development and manufacturing event, to "experience science through commercialization" through exhibits, networking and conferences to leverage quality, efficiency and cost effectiveness. INTERPHEX will take place from April 20 through the 22nd 2021, in New York City. And sponsored by Eurofins BioPharma Product Testing, Honeywell and Lonza Pharma & Biotech. Before we begin, some brief messages from the program sponsors.

Eurofins

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot